STAT+: PepGen says early trial for muscular dystrophy drug looks promising
· statnews.com · popularity 32/100 · 0 similar stories today
Read the original at statnews.com →
Summary
PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 6.